SS
Shivansh Sharma
About Shivansh Sharma
Shivansh Sharma has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Igain Consultancy Services Private Limited and Go4life Biotech Private Limited. Formerly with 3 companies, such as Kundarah Trading Corporation Private Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Rolling Blockchain Private Limited
U74999HR2019PTC080800
|
Director | 19 Sep 2023 | 2019 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
|
Kundarah Trading Corporation Private Limited
U24304HR2018PTC072886
|
Additional Director | 04 Dec 2023 | 2018 | Active |
|
Igain Consultancy Services Private Limited
U74900HR2013PTC050568
|
Director | 14 Feb 2024 | 2013 | Strike Off |
Go4life Biotech Private Limited
U24304HR2017PTC069421
|
Director | 14 Feb 2024 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shivansh Sharma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shivansh Sharma
Shivansh Sharma has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Igain Consultancy Services Private Limited and Go4life Biotech Private Limited. Formerly with 3 companies, such as Kundarah Trading Corporation Private Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Shivansh Sharma is associated with 1 company as Director.
Shivansh Sharma has expertise in General Business, Technology.
Shivansh Sharma has 2 years in corporate governance.